CASMED Receives FDA Approval for FORE-SIGHT ELITE in Non-Cerebral Tissue
GlobeNewswire - Wed May 07, 9:13AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced receipt of U.S. Food and Drug Administration (FDA) clearance of an expanded label claim for the Company's FORE-SIGHT ELITE(R) Oximeters for use in non-cerebral tissue of adults. This clearance will permit FORE-SIGHT ELITE oximeters to be marketed to clinicians to determine oxygen saturation of hemoglobin in musculoskeletal applications, and follows CASMED's submission of a 510(k) application.
CASMED Announces First Quarter 2014 Financial Results
GlobeNewswire - Thu May 01, 7:13AM CDT
FORE-SIGHT Sales Increase 24%
CASMED to Announce First Quarter 2014 Financial Results and Hold Conference Call on May 1st
GlobeNewswire - Tue Apr 22, 7:08AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the first quarter of 2014 on Thursday, May 1, 2014 prior to the market's opening. Management will host a conference call to discuss these results and answer questions beginning at 10:00 a.m. Eastern time that day.
CASMED Engages Gamida to Distribute FORE-SIGHT(R) Oximeters in France
GlobeNewswire - Wed Apr 16, 7:15AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that it has signed an agreement with Gamida to serve as the exclusive distributor of the Company's FORE-SIGHT(R) Cerebral Oximeters in France.
CASMED Places 1,000th FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Thu Mar 20, 7:00AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that the worldwide cumulative net shipment total of FORE-SIGHT Cerebral Oximeters reached 1,000 as of last week. This total includes monitors installed at nine of the top 20 adult cardiac surgery centers and three of the top ten pediatric centers in the U.S. The Company had previously disclosed a net cumulative total of 935 units as of December 31, 2013.
CAS Medical Systems elects Karen Harris-Coleman as EVP of International Sales
M2 - Wed Mar 19, 8:34AM CDT
Medical device company CAS Medical Systems (NasdaqCM:CASM) revealed on Tuesday the appointment of Karen Harris-Coleman as executive vice president of its International Sales.
CASMED Names Karen Harris-Coleman Executive Vice President, International Sales
GlobeNewswire - Tue Mar 18, 7:00AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it has named Karen Harris-Coleman as Executive Vice President, International Sales. Ms. Harris-Coleman has more than 20 years of general management and international sales and marketing experience in the medical device industry.
CASMED Announces Fourth Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Thu Mar 06, 8:24AM CST
Fourth Quarter U.S. FORE-SIGHT(R) Disposable Sales Increase 35%
CASMED to Present at 26th Annual ROTH Conference
GlobeNewswire - Wed Feb 26, 7:42AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the 26th Annual ROTH Conference on Tuesday, March 11, 2014, at 3:00 p.m. PT. The conference is being held at The Ritz Carlton in Dana Point, California, from March 9 to March 12.
CASMED to Announce Fourth Quarter and Full-Year 2013 Financial Results and Hold Conference Call on March 6
GlobeNewswire - Tue Feb 25, 7:10AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced today that it will report financial results for the fourth quarter and full-year 2013 on Thursday, March 6, 2014, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 A.M. (ET) that day.
2013 Report on the International Capnography Market 2012 - Forecasts to 2016
M2 - Mon Jan 13, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/g7h4gv/global) has announced the addition of the "2013 Report on the International Capnography Market 2012 - Forecasts to 2016" report to their offering. Advancements in capnography technology are allowing critical care providers to have a more accurate way of measuring CO2 in critical care patients. Although healthcare professionals have experienced major difficulties and limitations when using Mainstream and Sidestream capnography over the past few years, the latest Microstream capnography technology is expected to overcome those drawbacks. Microstream technology helps care providers monitor both intubated and non-intubated patients. Devices based on this technology can operate in extremely humid environments, in homecare, ambulatory services, and in hospitals. Microstream devices also offer improved moisture management to eliminate problems caused by blocked sample lines. One of the major growth drivers is the tremendous advancements in technology being made in the form of innovations that have led to the development of new-generation capnography devices. For example, Oridion's Microstream technology created a revolution in the Global Capnography market. Moreover, potential users in the APAC region are also expected to boost the market during the forecast period. These factors in combination with others are expected to drive the growth of the Global Capnography market during the forecast period. The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are CAS Medical Systems Inc., Diamedica Inc., Dragerwerk AG & Co. KGaA, GE Healthcare Ltd., Ivy Biomedical Systems Inc., Medtronic Inc., Nihon Kohden Corp. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - CAS Medical Systems - Covidien - Diamedica - Dragerwerk AG & Co. KGaA - GE Healthcare - Ivy Biomedical Systems - Medtronic - Nihon Kohden - Nonin Medical - OSI Systems - Opto Circuits (India) - Philips Healthcare - Smiths Medical - Triton Electronics - Weinmann Gerate fur Medizin - Welch Allyn Inc. For more information visit http://www.researchandmarkets.com/research/g7h4gv/global
Nasdaq stocks posting largest volume increases
AP - Wed Jan 08, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CASMED Reports Preliminary Sales for Fourth Quarter and Full Year 2013
GlobeNewswire - Wed Jan 08, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported preliminary top-line unaudited results for the fourth quarter and full year 2013.
Gitga'at First Nation Disappointed in Joint Review Panel Recommendation; Hopes Federal Government Will Reject Enbridge's Northern Gateway Project
Marketwire Canada - Thu Dec 19, 4:56PM CST
The Gitga'at First Nation is disappointed in the Joint Review Panel's recommendation on the Northern Gateway project, but is hopeful the Federal government will reject the project as inconsistent with its constitutional and international legal obligations to respect the rights of Aboriginal peoples and in the interest of building positive relationships with the Gitga'at and other BC First Nations.
CASMED Places 900th FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Tue Dec 03, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that the worldwide installed base of its FORE-SIGHT Cerebral Oximeters surpassed 900 in November. The installed base includes seven of the top 20 adult cardiac surgery centers and three of the top ten pediatric centers in the U.S. The Company had previously disclosed an installed base of 845 units as of September 30, 2013.
CASMED Receives China Food and Drug Administration Approval for FORE-SIGHT(R) Cerebral Oximeter
GlobeNewswire - Mon Nov 25, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that its FORE-SIGHT Cerebral Oximeter has been approved by the China Food and Drug Administration (CFDA) for sale in that country. FORE-SIGHT is the only cerebral oximeter manufactured outside China to have approval from the CDFA.
CASMED to Present at the LD MICRO MAIN EVENT Conference
GlobeNewswire - Thu Nov 21, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the sixth annual LD MICRO conference on Tuesday, December 3, 2013, at 3:30 p.m. Pacific time. The conference will be held at the Luxe Sunset Hotel in Los Angeles.
CASMED Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 7:00AM CST
Launch of Next-Generation Cerebral Oximetry Products Underway